HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 183 filers reported holding HEALTH CATALYST INC in Q2 2022. The put-call ratio across all filers is 6.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,060,121 | -3.2% | 500,012 | +19.6% | 0.01% | -9.1% |
| Q2 2023 | $5,224,851 | -57.4% | 417,988 | -60.3% | 0.01% | -64.5% |
| Q1 2023 | $12,276,443 | -30.3% | 1,051,966 | -36.5% | 0.03% | -35.4% |
| Q4 2022 | $17,602,706 | +59.2% | 1,655,946 | +45.3% | 0.05% | +41.2% |
| Q3 2022 | $11,054,000 | -19.7% | 1,139,579 | +20.0% | 0.03% | -24.4% |
| Q2 2022 | $13,764,000 | +131.6% | 949,925 | +533.3% | 0.04% | +125.0% |
| Q4 2021 | $5,943,000 | +1253.8% | 150,005 | +1151.9% | 0.02% | +566.7% |
| Q3 2020 | $439,000 | -32.7% | 11,982 | -41.9% | 0.00% | -25.0% |
| Q3 2019 | $652,000 | – | 20,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Norwest Venture Partners XI, LP | 876,045 | $32,063,000 | 100.00% |
| Norwest Venture Partners XII, LP | 876,045 | $32,063,000 | 69.68% |
| Nepsis Inc. | 197,178 | $7,217,000 | 3.46% |
| Karani Asset Management LLC | 133,968 | $4,903,000 | 3.29% |
| ADAMS STREET PARTNERS LLC | 201,548 | $6,639,000 | 1.75% |
| HHR Asset Management, LLC | 412,423 | $15,095,000 | 1.50% |
| Mesirow Financial Investment Management, Inc. | 9,510 | $348,000 | 1.49% |
| ASHFORD CAPITAL MANAGEMENT INC | 342,500 | $12,536,000 | 1.49% |
| Roubaix Capital, LLC | 31,889 | $1,167,000 | 1.38% |
| Monarch Partners Asset Management LLC | 154,847 | $5,667,000 | 1.28% |